These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22896673)

  • 61. Approaching Regulatory Approval of Cardiovascular Regenerative Therapy.
    Povsic TJ
    Circ Res; 2018 Feb; 122(4):552-554. PubMed ID: 29449363
    [No Abstract]   [Full Text] [Related]  

  • 62. An FDA perspective on preclinical development of cell-based regenerative medicine products.
    Bailey AM; Mendicino M; Au P
    Nat Biotechnol; 2014 Aug; 32(8):721-3. PubMed ID: 25093890
    [No Abstract]   [Full Text] [Related]  

  • 63. Regenerated human corneas restore vision.
    Regen Med; 2014; 9(4):415. PubMed ID: 25302359
    [No Abstract]   [Full Text] [Related]  

  • 64. Evaluating the FDA regenerative medicine framework: opportunities for stakeholders.
    Richardson E; Akkas F; Master Z
    Regen Med; 2020 Jul; 15(7):1825-1832. PubMed ID: 32815780
    [No Abstract]   [Full Text] [Related]  

  • 65. American Society for Artificial Internal Organs: the government's role in advancing regenerative medicine and tissue engineering.
    Zucker HA
    ASAIO J; 2004; 50(6):xix-xxi. PubMed ID: 15672773
    [No Abstract]   [Full Text] [Related]  

  • 66. An Overview of the Tissue Engineering Market in the United States from 2011 to 2018.
    Kim YS; Smoak MM; Melchiorri AJ; Mikos AG
    Tissue Eng Part A; 2019 Jan; 25(1-2):1-8. PubMed ID: 30027831
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Conditional Approval Pathways: The "Special" Case of Global Regenerative Medicine Regulation.
    Smith JA; Brindley DA
    Rejuvenation Res; 2017 Feb; 20(1):1-3. PubMed ID: 28125919
    [No Abstract]   [Full Text] [Related]  

  • 68. A brief definition of regenerative medicine.
    Mason C; Dunnill P
    Regen Med; 2008 Jan; 3(1):1-5. PubMed ID: 18154457
    [No Abstract]   [Full Text] [Related]  

  • 69. [The resolution of the XXVIII (91th) session of the RAMS General Meeting "Cell Technologies and Regenerative Medicine"].
    Dedov II; Tutel'ian VA
    Vestn Ross Akad Med Nauk; 2013; (9):4-6. PubMed ID: 24624865
    [No Abstract]   [Full Text] [Related]  

  • 70. Abstracts of the 3rd Malaysian Tissue Engineering and Regenerative Medicine (MTERM) Scientific Meeting 2010. October 13-14, 2010, Malaysia.
    Med J Malaysia; 2010 Oct; 65(2 Suppl B):1-120. PubMed ID: 22003555
    [No Abstract]   [Full Text] [Related]  

  • 71. Abstracts of the Tissue Engineering & Regenerative Medicine International Society, European Chapter Meeting, 10-13 june, 2014, Genova, Italy.
    J Tissue Eng Regen Med; 2014 Jun; 8 Suppl 1():1-518. PubMed ID: 24912685
    [No Abstract]   [Full Text] [Related]  

  • 72. Can regenerative medicine save Big Pharma’s business model from the patent cliff?
    Denoon A; Vollebregt E
    Regen Med; 2010 Sep; 5(5):687-90. PubMed ID: 20868323
    [No Abstract]   [Full Text] [Related]  

  • 73. Using Mathematical Modeling to Design Effective Regenerative Medicine Strategies for Orthopaedics.
    Robertson DD; Sharma GB; Boyan BD
    J Am Acad Orthop Surg; 2016 Jan; 24(1):e18-9. PubMed ID: 26609105
    [No Abstract]   [Full Text] [Related]  

  • 74. Donor considerations in regenerative medicine.
    Webb TL
    Vet J; 2016 Nov; 217():8-9. PubMed ID: 27810217
    [No Abstract]   [Full Text] [Related]  

  • 75. [Assessment of gene therapy and regenerative therapy using radionuclide technique].
    Inubushi M
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2010 May; 66(5):542-6. PubMed ID: 20628223
    [No Abstract]   [Full Text] [Related]  

  • 76. Peers call for UK to harness "enormous" potential of regenerative medicine.
    O'Dowd A
    BMJ; 2013 Jul; 347():f4248. PubMed ID: 23818565
    [No Abstract]   [Full Text] [Related]  

  • 77. Drug delivery design for regenerative medicine.
    Wang X
    Curr Pharm Des; 2015; 21(12):1503-5. PubMed ID: 25714104
    [No Abstract]   [Full Text] [Related]  

  • 78. Tissue engineering as a subdivision of bioprocess engineering: reparative tissue engineering as a subspecialty of tissue engineering.
    Kang KA
    Ann N Y Acad Sci; 2002 Jun; 961():216-9. PubMed ID: 12081904
    [No Abstract]   [Full Text] [Related]  

  • 79. Healthy ageing and regenerative medicine.
    Fraifeld VE
    Biogerontology; 2013 Dec; 14(6):569-71. PubMed ID: 24292550
    [No Abstract]   [Full Text] [Related]  

  • 80. Renewed Interest in Regenerative Medicine.
    EBioMedicine; 2018 Jan; 27():1-2. PubMed ID: 29413181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.